Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier
- 1 January 1996
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 14 (6) , 619-623
- https://doi.org/10.1016/0730-725x(96)00118-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Safety of gadoteridol injection: U.S. clinical trial experienceJournal of Magnetic Resonance Imaging, 1995
- Effects of Gd-DTPA after Osmotic BBB Disruption in a Rodent ModelJournal of Computer Assisted Tomography, 1994
- Preclinical Safety Assessment and Pharmacokinetics of Gadodiamide Injection, a New Magnetic Resonance Imaging Contrast AgentInvestigative Radiology, 1993
- Magnetic Resonance Imaging Contrast Agents Design and Physicochemical Properties of GadodiamideInvestigative Radiology, 1993
- Dissociation of gadolinium chelates in mice: Relationship to chemical characteristicsMagnetic Resonance Imaging, 1992
- MR imaging of cerebral lesions accompanying stroke in stroke-prone spontaneously hypertensive rats.Folia Pharmacologica Japonica, 1992
- Effect of Water-Soluble Contrast Medium on the Lung in Rats Comparison of Iotrolan, Iopamidol, and DiatrizoateInvestigative Radiology, 1990
- Contrast Enhanced MRIInvestigative Radiology, 1985
- The use of GD DTPA as a perfusion agent and marker of blood-brain barrier disruptionMagnetic Resonance Imaging, 1985
- Introduction: State of the Art and Design Principles of Contrast MediaPublished by Springer Nature ,1984